Boiron S.A.
BOIRF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$546.91M
Close$
$84.69
168.9% upside
Current Fair Value
168.9% upsideUndervalued by 168.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $546.91 Million |
|---|---|
| Enterprise Value | $525.03 Million |
| Annual dividend | $1.57 |
| Dividend yield | 7.22% |
| Earnings per Share | $1.88 |
| Beta | 0.22 |
| Outstanding Shares | 17,362,275 |
Return
| Return on Equity | 12.14% |
|---|---|
| Return on Assets | 8.01% |
| Return on Invested Capital | 9.48% |
Valuation & Multiples
| P/E Ratio | 12.55 |
|---|---|
| PEG | -21.97 |
| Price to Sales | 0.55 |
| Price to Book Ratio | 1.5 |
| Enterprise Value to Revenue | 0.53 |
| Enterprise Value to EBIT | 12.24 |
| Enterprise Value to Net Income | 11 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.08 |
Revenue Sources
No data
Next Earnings Call
Expected Date
March 24, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Boiron S.A.
2,634 employees
CEO: Pascal Houdayer
Boiron S.A., founded in Messimy, France, in 1932, is a pharmaceutical company dedicated to the production and global sale of homeopathic medicines. Its market presence spans France, the broader European continent, North America, and nume...